BioNTech (BNTX) Reports Q4 Loss of EUR0.33/Share as COVID Vaccine Revenue Plunges; Founders Exit
BioNTech posts wider-than-expected Q4 loss of $0.33/share as COVID vaccine revenue plunges 24% year-over-year; founders to exit for new mRNA venture.
9 articles, transcripts, and reports
BioNTech posts wider-than-expected Q4 loss of $0.33/share as COVID vaccine revenue plunges 24% year-over-year; founders to exit for new mRNA venture.
BioNTech SE (NASDAQ: BNTX) Q2 2022 Earnings Conference
BioNTech SE (NASDAQ: BNTX) Q1 2022 Earnings Conference
BioNTech SE (NASDAQ: BNTX) Q4 2021 Earnings Conference
BioNTech SE (NASDAQ: BNTX) Q3 2021 Earnings Conference
BioNTech SE (NASDAQ: BNTX) Q2 2021 Earnings Conference
BioNTech SE (NASDAQ: BNTX) Q1 2021 Earnings Conference
BioNTech SE (NASDAQ: BNTX) Q4 2020 Earnings Conference